Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1979 Jun;66(2):235–240. doi: 10.1111/j.1476-5381.1979.tb13671.x

Cardiovascular responses produced by the injection of dopamine into the cerebral ventricles of the unanaesthetized dog.

W J Lang, O L Woodman
PMCID: PMC2043642  PMID: 465876

Abstract

1 The injection of dopamine (100 to 500 microgram) into the cerebral ventricles (i.c.v.) of 10 unanaesthetized dogs produced a dose-dependent increase in arterial blood pressure and heart rate. The dogs licked, swallowed, sometimes vomited and became sedated. 2 Autonomic ganglion blockade with hexamethonium (10 mg/kg i.v.) abolished cardiovascular responses to i.c.v. dopamine, indicating that dopamine was exerting its effect within the central nervous system. 3 The dopamine receptor antagonists, haloperidol (500 microgram), chlorpromazine (200 micrograms) and ergometrine (500 micrograms), each given i.c.v., sugsequently abolished the cardiovascular responses to dopamine. 4 Pretreatment with either the beta-adrenoceptor antagonist, propranolol (600 microgram) or the alpha-adrenoceptor antagonist, phentolamine (1 mg) given i.c.v. had no significant effect on the response to dopamine. 5 It is suggested that dopamine injected into the cerebral ventricles of the unanesthetized dog causes hypertension and tachycardia by activating central dopamine receptors.

Full text

PDF
235

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson W. P., Korner P. I., Bobik A., Chalmers J. P. Leakage of dl-propranolol from cerebrospinal fluid to the bloodstream in the rabbit. J Pharmacol Exp Ther. 1977 Aug;202(2):320–325. [PubMed] [Google Scholar]
  2. Baum T., Shropshire A. T. Reduction of sympathetic outflow by central administration of L-DOPA, dopamine and norepinephrine. Neuropharmacology. 1973 Jan;12(1):49–56. doi: 10.1016/0028-3908(73)90131-7. [DOI] [PubMed] [Google Scholar]
  3. Bell C., Conway E. L., Lang W. J., Padanyi R. Vascular dopamine receptors in the canine hindlimb. Br J Pharmacol. 1975 Oct;55(2):167–172. doi: 10.1111/j.1476-5381.1975.tb07625.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bolme P., Fuxe K., Lidbrink P. On the function of central catecholamine neurons--their role in cardiovascular and arousal mechanisms. Res Commun Chem Pathol Pharmacol. 1972 Nov;4(3):657–697. [PubMed] [Google Scholar]
  5. Buylaert W. A., Willems J. L., Bogaert M. G. Vasodilatation produced by apomorphine in the hindleg of the dog. J Pharmacol Exp Ther. 1977 Jun;201(3):738–746. [PubMed] [Google Scholar]
  6. Carlsson A. Some aspects of dopamine in the central nervous system. Adv Neurol. 1974;5:59–68. [PubMed] [Google Scholar]
  7. Conway E. L., Lang W. J. Cardiovascular responses produced by the injection of isoprenaline and propranolol into the cerebral ventricles of the unanaesthetized dog. Clin Exp Pharmacol Physiol. 1974 Jan-Feb;1(1):59–64. doi: 10.1111/j.1440-1681.1974.tb00527.x. [DOI] [PubMed] [Google Scholar]
  8. Day M. D., Roach A. G. Cardiovascular effects of dopamine after central administration into conscious cats. Br J Pharmacol. 1976 Dec;58(4):505–515. doi: 10.1111/j.1476-5381.1976.tb08617.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Dutta S. N., Guha D., Pradhan S. N. Cardiovascular effects of central microinjections of apomorphin in cats. Arch Int Pharmacodyn Ther. 1975 Jun;215(2):259–265. [PubMed] [Google Scholar]
  10. Goldberg L. I. Comparison of putative dopamine receptors in blood vessels and the central nervous system. Adv Neurol. 1975;9:53–56. [PubMed] [Google Scholar]
  11. Heise A., Kroneberg G. Central nervous alpha-adrenergic receptors and the mode of action of alpha-methyldopa. Naunyn Schmiedebergs Arch Pharmacol. 1973;279(3):285–300. doi: 10.1007/BF00500607. [DOI] [PubMed] [Google Scholar]
  12. Higgins C. B., Millard R. W., Braunwald E., Vatner S. F. Effects and mechanisms of action of dopamine on regional hemodynamics in the conscious dog. Am J Physiol. 1973 Aug;225(2):432–437. doi: 10.1152/ajplegacy.1973.225.2.432. [DOI] [PubMed] [Google Scholar]
  13. Hornykiewicz O. Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA). Br Med Bull. 1973 May;29(2):172–178. doi: 10.1093/oxfordjournals.bmb.a070990. [DOI] [PubMed] [Google Scholar]
  14. LANG W., GERSHON S., HOLAN G. SOME ANTAGONISTS OF ATROPINE-LIKE PSYCHOTOMIMETICS. J Pharm Pharmacol. 1963 Dec;15:831–840. doi: 10.1111/j.2042-7158.1963.tb12888.x. [DOI] [PubMed] [Google Scholar]
  15. Lang W. J., Rush M. L. Cardiovascular responses to injections of cholinomimetic drugs into the cerebral ventricles of unanaesthetized dogs. Br J Pharmacol. 1973 Feb;47(2):196–205. doi: 10.1111/j.1476-5381.1973.tb08317.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MCCUBBIN J. W., KANEKO Y., PAGE I. H. Ability of serotonin and norepinephrine to mimic the central effects of reserpine on vasomotor activity. Circ Res. 1960 Jul;8:849–858. doi: 10.1161/01.res.8.4.849. [DOI] [PubMed] [Google Scholar]
  17. McNay J. L., Goldberg L. I. Comparison of the effects of dopamine, isoproterenol, norepinephrine and bradykinin on canine renal and femoral blood flow. J Pharmacol Exp Ther. 1966 Jan;151(1):23–31. [PubMed] [Google Scholar]
  18. PRICE H. L. General anesthesia and circulatory homeostasis. Physiol Rev. 1960 Apr;40:187–218. doi: 10.1152/physrev.1960.40.2.187. [DOI] [PubMed] [Google Scholar]
  19. Pendleton R. G., Setler P. E. Peripheral cardiovascular dopamine receptors. Gen Pharmacol. 1977;8(1):1–5. doi: 10.1016/0306-3623(77)90056-8. [DOI] [PubMed] [Google Scholar]
  20. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl. 1971;367:69–93. doi: 10.1111/j.1365-201x.1971.tb11000.x. [DOI] [PubMed] [Google Scholar]
  21. Woodruff G. N., Elkhawad A. O., Crossman A. R. Further evidence for the stimulation of rat brain dopamine receptors by ergometrine. J Pharm Pharmacol. 1974 Jun;26(6):455–456. doi: 10.1111/j.2042-7158.1974.tb09313.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES